The pharmacokinetics of acebvutolol in m
β
A. A. Gulaid; I. M. James; C. M. Kaye; O. R. W. Lewellen; E. Roberts; M. Sankey;
π
Article
π
1981
π
John Wiley and Sons
π
English
β 508 KB
## Abstract The pharmacokinetics of acebutolol have been studied in eight healthy male volunteers following the oral administration of acebutolol hydrochloride (βSectralβ, May & Baker) as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d. for 56 days). Following single